Alessandro Russo, Andrés F Cardona, Christian Caglevic, Paolo Manca, Alejandro Ruiz-Patiño, Oscar Arrieta, Christian Rolfo. Transl Lung Cancer Res 2020
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Tao Bai, Pengxu Lei, Hao Zhou, Ruopeng Liang, Rongtao Zhu, Weijie Wang, Lin Zhou, Yuling Sun. J Cell Mol Med 2019
Tao Bai, Pengxu Lei, Hao Zhou, Ruopeng Liang, Rongtao Zhu, Weijie Wang, Lin Zhou, Yuling Sun. J Cell Mol Med 2019
25
Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis.
Ji-Ning Jia, Xi-Xi Yin, Qin Li, Qi-Wen Guan, Nan Yang, Kang-Ni Chen, Hong-Hao Zhou, Xiao-Yuan Mao. Front Pharmacol 2020
Ji-Ning Jia, Xi-Xi Yin, Qin Li, Qi-Wen Guan, Nan Yang, Kang-Ni Chen, Hong-Hao Zhou, Xiao-Yuan Mao. Front Pharmacol 2020
25
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers.
Bowen Li, Liang Yang, Xueqiang Peng, Qin Fan, Shibo Wei, Shuo Yang, Xinyu Li, Hongyuan Jin, Bo Wu, Mingyao Huang,[...]. Biomed Pharmacother 2020
Bowen Li, Liang Yang, Xueqiang Peng, Qin Fan, Shibo Wei, Shuo Yang, Xinyu Li, Hongyuan Jin, Bo Wu, Mingyao Huang,[...]. Biomed Pharmacother 2020
25
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients.
J Remon, C E Steuer, S S Ramalingam, E Felip. Ann Oncol 2018
J Remon, C E Steuer, S S Ramalingam, E Felip. Ann Oncol 2018
25
Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance.
Sylvia S Gayle, Samuel L M Arnold, Ruth M O'Regan, Rita Nahta. Anticancer Agents Med Chem 2012
Sylvia S Gayle, Samuel L M Arnold, Ruth M O'Regan, Rita Nahta. Anticancer Agents Med Chem 2012
25
Global Epidemiology of Lung Cancer.
Julie A Barta, Charles A Powell, Juan P Wisnivesky. Ann Glob Health 2019
Julie A Barta, Charles A Powell, Juan P Wisnivesky. Ann Glob Health 2019
25
Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Xuefei Zhang, Shiyao Sui, Lingling Wang, Haixia Li, Lei Zhang, Shouping Xu, Xiulan Zheng. J Cell Physiol 2020
Xuefei Zhang, Shiyao Sui, Lingling Wang, Haixia Li, Lei Zhang, Shouping Xu, Xiulan Zheng. J Cell Physiol 2020
25
Translational regulation of GPx-1 and GPx-4 by the mTOR pathway.
Emily N Reinke, Dede N Ekoue, Soumen Bera, Nadim Mahmud, Alan M Diamond. PLoS One 2014
Emily N Reinke, Dede N Ekoue, Soumen Bera, Nadim Mahmud, Alan M Diamond. PLoS One 2014
25
Role of GPX4 in ferroptosis and its pharmacological implication.
Tobias M Seibt, Bettina Proneth, Marcus Conrad. Free Radic Biol Med 2019
Tobias M Seibt, Bettina Proneth, Marcus Conrad. Free Radic Biol Med 2019
25
Cancer, Oxidative Stress, and Metastasis.
Jennifer G Gill, Elena Piskounova, Sean J Morrison. Cold Spring Harb Symp Quant Biol 2016
Jennifer G Gill, Elena Piskounova, Sean J Morrison. Cold Spring Harb Symp Quant Biol 2016
25
DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
Shunnan Yao, Jianpin Ye, Mengqi Yin, Rui Yu. Cancer Lett 2020
Shunnan Yao, Jianpin Ye, Mengqi Yin, Rui Yu. Cancer Lett 2020
25
25
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer.
Sanne C F A Huijberts, Robin M J M van Geel, Emilie M J van Brummelen, Frans L Opdam, Serena Marchetti, Neeltje Steeghs, Saskia Pulleman, Bas Thijssen, Hilde Rosing, Kim Monkhorst,[...]. Cancer Chemother Pharmacol 2020
Sanne C F A Huijberts, Robin M J M van Geel, Emilie M J van Brummelen, Frans L Opdam, Serena Marchetti, Neeltje Steeghs, Saskia Pulleman, Bas Thijssen, Hilde Rosing, Kim Monkhorst,[...]. Cancer Chemother Pharmacol 2020
25
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib.
Xiang Song, Xinzhao Wang, Zhaoyun Liu, Zhiyong Yu. Front Oncol 2020
Xiang Song, Xinzhao Wang, Zhaoyun Liu, Zhiyong Yu. Front Oncol 2020
25
Anti-tumor effects of Atractylenolide I on bladder cancer cells.
Rui Yu, Bi-Xia Yu, Jun-Feng Chen, Xiu-Yi Lv, Ze-Jun Yan, Yue Cheng, Qi Ma. J Exp Clin Cancer Res 2016
Rui Yu, Bi-Xia Yu, Jun-Feng Chen, Xiu-Yi Lv, Ze-Jun Yan, Yue Cheng, Qi Ma. J Exp Clin Cancer Res 2016
25
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.
Brent R Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, Ashley I Bush, Marcus Conrad, Scott J Dixon, Simone Fulda, Sergio Gascón, Stavroula K Hatzios, Valerian E Kagan,[...]. Cell 2017
Brent R Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, Ashley I Bush, Marcus Conrad, Scott J Dixon, Simone Fulda, Sergio Gascón, Stavroula K Hatzios, Valerian E Kagan,[...]. Cell 2017
25
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).
Ana C Z Gelatti, Alexander Drilon, Fernando C Santini. Lung Cancer 2019
Ana C Z Gelatti, Alexander Drilon, Fernando C Santini. Lung Cancer 2019
25
mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation.
Yilei Zhang, Robert V Swanda, Litong Nie, Xiaoguang Liu, Chao Wang, Hyemin Lee, Guang Lei, Chao Mao, Pranavi Koppula, Weijie Cheng,[...]. Nat Commun 2021
Yilei Zhang, Robert V Swanda, Litong Nie, Xiaoguang Liu, Chao Wang, Hyemin Lee, Guang Lei, Chao Mao, Pranavi Koppula, Weijie Cheng,[...]. Nat Commun 2021
25
25
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels.
Gloria E Villalpando-Rodriguez, Anna R Blankstein, Carmen Konzelman, Spencer B Gibson. Oxid Med Cell Longev 2019
Gloria E Villalpando-Rodriguez, Anna R Blankstein, Carmen Konzelman, Spencer B Gibson. Oxid Med Cell Longev 2019
25
Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer.
Sara Redaelli, Monica Ceccon, Marina Zappa, Geeta G Sharma, Cristina Mastini, Mario Mauri, Marion Nigoghossian, Luca Massimino, Nicoletta Cordani, Francesca Farina,[...]. Cancer Res 2018
Sara Redaelli, Monica Ceccon, Marina Zappa, Geeta G Sharma, Cristina Mastini, Mario Mauri, Marion Nigoghossian, Luca Massimino, Nicoletta Cordani, Francesca Farina,[...]. Cancer Res 2018
25
Sodium valproate, a histone deacetylase inhibitor ameliorates cyclophosphamide-induced genotoxicity and cytotoxicity in the colon of mice.
Sabbir Khan, Gopabandhu Jena. J Basic Clin Physiol Pharmacol 2014
Sabbir Khan, Gopabandhu Jena. J Basic Clin Physiol Pharmacol 2014
25
Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma.
M Ceccon, L Mologni, G Giudici, R Piazza, A Pirola, D Fontana, C Gambacorti-Passerini. Mol Cancer Res 2015
M Ceccon, L Mologni, G Giudici, R Piazza, A Pirola, D Fontana, C Gambacorti-Passerini. Mol Cancer Res 2015
25
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
R M Mohammad, N R Wall, J A Dutcher, A M Al-Katib. Clin Cancer Res 2000
R M Mohammad, N R Wall, J A Dutcher, A M Al-Katib. Clin Cancer Res 2000
25
Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death.
Avedis Torossian, Nicolas Broin, Julie Frentzel, Camille Daugrois, Sarah Gandarillas, Talal Al Saati, Laurence Lamant, Pierre Brousset, Sylvie Giuriato, Estelle Espinos. Haematologica 2019
Avedis Torossian, Nicolas Broin, Julie Frentzel, Camille Daugrois, Sarah Gandarillas, Talal Al Saati, Laurence Lamant, Pierre Brousset, Sylvie Giuriato, Estelle Espinos. Haematologica 2019
25
Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1.
Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig, Donald A Barkauskas, Rui Wu, Sarah Alexander, Catherine M Bollard. Blood 2021
Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig, Donald A Barkauskas, Rui Wu, Sarah Alexander, Catherine M Bollard. Blood 2021
25
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib.
S Redaelli, F Boschelli, P Perini, A Pirola, M Viltadi, C Gambacorti-Passerini. Leukemia 2010
S Redaelli, F Boschelli, P Perini, A Pirola, M Viltadi, C Gambacorti-Passerini. Leukemia 2010
25
BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells.
Elisa Sala, Luca Mologni, Silvia Truffa, Carlo Gaetano, Gideon E Bollag, Carlo Gambacorti-Passerini. Mol Cancer Res 2008
Elisa Sala, Luca Mologni, Silvia Truffa, Carlo Gaetano, Gideon E Bollag, Carlo Gambacorti-Passerini. Mol Cancer Res 2008
25
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells.
Chiara Ambrogio, Cinzia Martinengo, Claudia Voena, Fabrizio Tondat, Ludovica Riera, Paola Francia di Celle, Giorgio Inghirami, Roberto Chiarle. Cancer Res 2009
Chiara Ambrogio, Cinzia Martinengo, Claudia Voena, Fabrizio Tondat, Ludovica Riera, Paola Francia di Celle, Giorgio Inghirami, Roberto Chiarle. Cancer Res 2009
25
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.
Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana, Collin M Blakely, Ross A Okimoto, Luping Lin, Dana S Neel, Amit Sabnis,[...]. Nat Med 2015
Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana, Collin M Blakely, Ross A Okimoto, Luping Lin, Dana S Neel, Amit Sabnis,[...]. Nat Med 2015
25
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.
Ting-Chao Chou. Pharmacol Rev 2006
Ting-Chao Chou. Pharmacol Rev 2006
25
Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy.
Meghan Leary, Sarah Heerboth, Karolina Lapinska, Sibaji Sarkar. Cancers (Basel) 2018
Meghan Leary, Sarah Heerboth, Karolina Lapinska, Sibaji Sarkar. Cancers (Basel) 2018
25
Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors.
Monica Ceccon, Luca Mologni, William Bisson, Leonardo Scapozza, Carlo Gambacorti-Passerini. Mol Cancer Res 2013
Monica Ceccon, Luca Mologni, William Bisson, Leonardo Scapozza, Carlo Gambacorti-Passerini. Mol Cancer Res 2013
25
Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
Melanie R Hassler, Aleksandra Klisaroska, Karoline Kollmann, Irene Steiner, Martin Bilban, Ana-Iris Schiefer, Veronika Sexl, Gerda Egger. Biochimie 2012
Melanie R Hassler, Aleksandra Klisaroska, Karoline Kollmann, Irene Steiner, Martin Bilban, Ana-Iris Schiefer, Veronika Sexl, Gerda Egger. Biochimie 2012
25
NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma.
E Pomari, G Basso, S Bresolin, M Pillon, E Carraro, E S d'Amore, G Viola, C Frasson, K Basso, P Bonvini,[...]. Leukemia 2017
E Pomari, G Basso, S Bresolin, M Pillon, E Carraro, E S d'Amore, G Viola, C Frasson, K Basso, P Bonvini,[...]. Leukemia 2017
25
IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK.
Qian Zhang, Hong Yi Wang, Xiaobin Liu, Gauri Bhutani, Kanchan Kantekure, Mariusz Wasik. Proc Natl Acad Sci U S A 2011
Qian Zhang, Hong Yi Wang, Xiaobin Liu, Gauri Bhutani, Kanchan Kantekure, Mariusz Wasik. Proc Natl Acad Sci U S A 2011
25
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.
Justin F Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo-Jack, Shirish Gadgeel, Katherine Schultz, Manrose Singh,[...]. Cancer Discov 2016
Justin F Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo-Jack, Shirish Gadgeel, Katherine Schultz, Manrose Singh,[...]. Cancer Discov 2016
25
The anaplastic lymphoma kinase in the pathogenesis of cancer.
Roberto Chiarle, Claudia Voena, Chiara Ambrogio, Roberto Piva, Giorgio Inghirami. Nat Rev Cancer 2008
Roberto Chiarle, Claudia Voena, Chiara Ambrogio, Roberto Piva, Giorgio Inghirami. Nat Rev Cancer 2008
25
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma.
Nathan F Moore, Anna M Azarova, Namrata Bhatnagar, Kenneth N Ross, Lauren E Drake, Stacey Frumm, Qinsong S Liu, Amanda L Christie, Takaomi Sanda, Louis Chesler,[...]. Oncotarget 2014
Nathan F Moore, Anna M Azarova, Namrata Bhatnagar, Kenneth N Ross, Lauren E Drake, Stacey Frumm, Qinsong S Liu, Amanda L Christie, Takaomi Sanda, Louis Chesler,[...]. Oncotarget 2014
25
Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.
Rocco Piazza, Vera Magistroni, Angela Mogavero, Federica Andreoni, Chiara Ambrogio, Roberto Chiarle, Luca Mologni, Petra S Bachmann, Richard B Lock, Paola Collini,[...]. Neoplasia 2013
Rocco Piazza, Vera Magistroni, Angela Mogavero, Federica Andreoni, Chiara Ambrogio, Roberto Chiarle, Luca Mologni, Petra S Bachmann, Richard B Lock, Paola Collini,[...]. Neoplasia 2013
25
p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function.
Stefania Mattiussi, Paolo Turrini, Lucia Testolin, Fabio Martelli, Germana Zaccagnini, Antonella Mangoni, Laura M Barlucchi, Annalisa Antonini, Barbara Illi, Corrado Cirielli,[...]. Cardiovasc Res 2004
Stefania Mattiussi, Paolo Turrini, Lucia Testolin, Fabio Martelli, Germana Zaccagnini, Antonella Mangoni, Laura M Barlucchi, Annalisa Antonini, Barbara Illi, Corrado Cirielli,[...]. Cardiovasc Res 2004
25
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Farhad Ravandi, Susan M O'Brien, Jorge E Cortes, Deborah M Thomas, Rebecca Garris, Stefan Faderl, Jan A Burger, Michael E Rytting, Alessandra Ferrajoli, William G Wierda,[...]. Cancer 2015
Farhad Ravandi, Susan M O'Brien, Jorge E Cortes, Deborah M Thomas, Rebecca Garris, Stefan Faderl, Jan A Burger, Michael E Rytting, Alessandra Ferrajoli, William G Wierda,[...]. Cancer 2015
25
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.
Carlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, Fadi Braiteh, Huiqiang Huang, Taito Esaki, Keizo Horibe, Jin-Seok Ahn, Joseph T Beck, William Jeffrey Edenfield,[...]. Am J Hematol 2018
Carlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, Fadi Braiteh, Huiqiang Huang, Taito Esaki, Keizo Horibe, Jin-Seok Ahn, Joseph T Beck, William Jeffrey Edenfield,[...]. Am J Hematol 2018
25
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.
Matteo Menotti, Chiara Ambrogio, Taek-Chin Cheong, Chiara Pighi, Ines Mota, Seth H Cassel, Mara Compagno, Qi Wang, Riccardo Dall'Olio, Valerio G Minero,[...]. Nat Med 2019
Matteo Menotti, Chiara Ambrogio, Taek-Chin Cheong, Chiara Pighi, Ines Mota, Seth H Cassel, Mara Compagno, Qi Wang, Riccardo Dall'Olio, Valerio G Minero,[...]. Nat Med 2019
25
Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.
Mi Ran Yun, Sun Min Lim, Seon-Kyu Kim, Hun Mi Choi, Kyoung-Ho Pyo, Seong Keun Kim, Ji Min Lee, You Won Lee, Jae Woo Choi, Hye Ryun Kim,[...]. Cancer Res 2018
Mi Ran Yun, Sun Min Lim, Seon-Kyu Kim, Hun Mi Choi, Kyoung-Ho Pyo, Seong Keun Kim, Ji Min Lee, You Won Lee, Jae Woo Choi, Hye Ryun Kim,[...]. Cancer Res 2018
25
STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression.
Qian Zhang, Hong Y Wang, Xiaobin Liu, Mariusz A Wasik. Nat Med 2007
Qian Zhang, Hong Y Wang, Xiaobin Liu, Mariusz A Wasik. Nat Med 2007
25
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.
Carlo Gambacorti Passerini, Francesca Farina, Alessandra Stasia, Sara Redaelli, Monica Ceccon, Luca Mologni, Cristina Messa, Luca Guerra, Giovanni Giudici, Elena Sala,[...]. J Natl Cancer Inst 2014
Carlo Gambacorti Passerini, Francesca Farina, Alessandra Stasia, Sara Redaelli, Monica Ceccon, Luca Mologni, Cristina Messa, Luca Guerra, Giovanni Giudici, Elena Sala,[...]. J Natl Cancer Inst 2014
25
Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
Kinnimulki Vijayachandra, William Higgins, Jessica Lee, Adam Glick. Mol Carcinog 2009
Kinnimulki Vijayachandra, William Higgins, Jessica Lee, Adam Glick. Mol Carcinog 2009
25
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells.
Luca Mologni, Stefania Brussolo, Monica Ceccon, Carlo Gambacorti-Passerini. PLoS One 2012
Luca Mologni, Stefania Brussolo, Monica Ceccon, Carlo Gambacorti-Passerini. PLoS One 2012
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.